Edgewise Therapeutics Inc (EWTX)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| CEO: | Kevin Koch |
| Employees: | 60 |
| Web site: | edgewisetx.com |
|
1715 38TH ST, BOULDER, CO, 80301
720-262-7002
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Edgewise Therapeutics, Inc. develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy.